CVS Group plc (LON:CVSG – Get Free Report) has been assigned an average rating of “Moderate Buy” from the six research firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 1,666.67.
A number of equities analysts have recently weighed in on the company. Berenberg Bank reiterated a “buy” rating and set a GBX 2,000 price target on shares of CVS Group in a report on Thursday, September 24th. Shore Capital Group restated a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a report on Thursday, September 24th. Deutsche Bank reaffirmed a “buy” rating and issued a GBX 1,700 target price on shares of CVS Group in a research report on Monday, July 27th. Finally, Jefferies Financial Group reaffirmed a “hold” rating and issued a GBX 1,400 target price on shares of CVS Group in a research report on Friday, September 25th.
Get Our Latest Stock Analysis on CVS Group
CVS Group Price Performance
CVSG stock opened at GBX 1,412 on Friday. The business has a fifty day moving average of GBX 1,285.08 and a two-hundred day moving average of GBX 1,255.45. The company has a quick ratio of 0.90, a current ratio of 1.18 and a debt-to-equity ratio of 110.41. The stock has a market cap of £941.73 million, a price-to-earnings ratio of 58.11, a price-to-earnings-growth ratio of 1.77 and a beta of 1.04. CVS Group has a 52-week low of GBX 1,062 and a 52-week high of GBX 1,428.
CVS Group (LON:CVSG – Get Free Report) last posted its earnings results on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. As a group, research analysts anticipate that CVS Group will post 93.94 earnings per share for the current year.
CVS Group Company Profile
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).
Further Reading
- Five stocks we like better than CVS Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
